Immunai

📍 New York, United States🗓 Founded 2019👥 154 employees💰 Last funded Jan 2021
Biotechnology Research🌐 immunai.com
Website LinkedIn
Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
2
Frequently asked questions
Who invested in Immunai?
Immunai has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Immunai last raise funding?
The most recent investment in Immunai recorded on gritt.io was in January 2021.
When was Immunai founded?
Immunai was founded in 2019.
What industry is Immunai in?
Immunai operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Immunai based?
Immunai is headquartered in New York, United States.